Physician profile
Richard Powell
NPI 1780620963
$855.54
in general payments reported to CMS, 2019-2025
12 companies · $336 in 2025
The $336 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $28.86 · 2021: $77.61 · 2022: $193 · 2023: $84.17 · 2024: $135 · 2025: $336.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $538 · Education: $17.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $538.23 |
| Education | $17.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $395.96 | 2022-2025 | Nucala, Trelegy Ellipta |
| Insmed, INC. | $264.17 | 2021-2025 | Arikayce, Brinsupri |
| Grifols USA, LLC | $32.92 | 2025 | Prolastin-C Liquid |
| Phadia US INC. | $31.27 | 2021-2022 | |
| Philips North America LLC | $28.86 | 2020 | |
| Mylan Specialty L.P. | $24.72 | 2022 | |
| Vapotherm INC | $24.42 | 2023 | Vapotherm |
| Baxter Healthcare | $21.44 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Olympus America INC. | $15.93 | 2021 | |
| Janssen Pharmaceuticals, INC | $15.85 | 2022 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Powell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.